Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01347723 · ClinicalTrials.gov registry record
Scrambler Therapy in Treating Pain and Peripheral Neuropathy in Patients Previously Treated With Chemotherapy
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 194
- Enrollment target
NCT01347723: Completed study, sponsored by Mayo Clinic.
NCT01347723 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 194 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01347723 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 194 participants
- Enrollment target
Study Summary
This pilot clinical trial studies scrambler therapy in treating pain and peripheral neuropathy in patients previously treated with chemotherapy. Scrambler therapy may help relieve pain from peripheral neuropathy caused by chemotherapy
Interventions
- OTHER questionnaire administration
- PROCEDURE management of therapy complications
- OTHER scrambler therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 194 participants |
| Start Date | 2011-03 |
| Est. Completion | 2015-12 |
What the finished NCT01347723 record still lists
NCT01347723 is an observational study that tracks outcomes without assigning an intervention. The registered 194 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 3 interventions - of which questionnaire administration is the first listed.
NCT01347723 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01347723 about?
NCT01347723 is a clinical study titled "Scrambler Therapy in Treating Pain and Peripheral Neuropathy in Patients Previously Treated With Chemotherapy". This pilot clinical trial studies scrambler therapy in treating pain and peripheral neuropathy in patients previously treated with chemotherapy. Scrambler therapy may help relieve pain from peripheral neuropathy caused by chemotherapy
What is the current status of trial NCT01347723?
This trial is currently completed. The enrollment target is 194 participants. The study started on 2011-03. Estimated completion is 2015-12.
What interventions are being tested in trial NCT01347723?
The interventions under investigation include: questionnaire administration (OTHER), management of therapy complications (PROCEDURE), scrambler therapy (OTHER).
Who is sponsoring clinical trial NCT01347723?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03593759 · 194 participants · Phase 3
Cardiac Sarcoidosis Randomized Trial
- NCT05053152 · 194 participants · Phase 2
Testing the Addition of the Drug Relugolix to the Usual Radiation Therapy for Advanced-Stage Prostate Cancer, The NRG Promethean Study
- NCT05156112 · 194 participants · NA
OSA PAP Treatment for Veterans With SUD and PTSD on Residential Treatment Unit
- NCT05351424 · 194 participants · NA
AVI Didactic Experience for Latinx Patient Treatment Adherence and Non-English Speaker Trial Enrollment Study in Rad Onc
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia